Excellent Strategic Management Showcased
JOHNSON & JOHNSON (J&J)
Headquartered in New Brunswick, New Jersey, Johnson & Johnson (J&J) is a global pharmaceutical, medical devices, and consumer packaged goods manufacturer that consistently ranks at the top of Harris Interactive’s National Corporate Reputation Survey. It was also recently ranked as the world’s most respected company by Barron’s Magazine.
J&J includes some 250 Subsidiary companies with operations in 60 countries employing approximately 116,000 people worldwide. J&J implements a decentralized management approach as each of its operating companies functions as its own small business. Selling products in over 175 countries, J&J’s brands are recognized all over the world. J&J brands include numerous household names of medications and first aid supplies such as the Band-Aid brand line of bandages, Tylenol medications, Johnson’s baby products, Neutrogena skin and beauty products, Clean & Clear facial wash, and Acuvue contact lenses.
J&J has had 27 consecutive years of adjusted earnings increases; and 49 consecutive years of dividend increases. Over the last 10 years, J&J stock generated a 4.0 percent total return for investors compared to a 1.4 percent total return for the S&P 500.
J&J had sales of $16.6 billion for the second quarter of 2011, an increase of 8.3 percent as compared to the second quarter of 2010. Domestic sales increased only 0.1 percent, while international sales increased 15.9 percent. J&J’s Worldwide Pharmaceutical sales of $6.2 billion for the second quarter represented an increase of 12.2 percent versus the prior year. Domesticsales increased 4.1 percent but international sales increased 22.6 percent. J&J’s Worldwide Medical Devices and Diagnostics sles of $6.6 billion for the second quarter of 2011 represented increases of 7.2 and 13.4 percent, respectively, versus the prior year dometic and international sales.
Excellent Strategic Management ShowcasedJOHNSON & JOHNSON (J&J)Headquartered in New Brunswick, New Jersey, Johnson & Johnson (J&J) is a global pharmaceutical, medical devices, and consumer packaged goods manufacturer that consistently ranks at the top of Harris Interactive’s National Corporate Reputation Survey. It was also recently ranked as the world’s most respected company by Barron’s Magazine. J&J includes some 250 Subsidiary companies with operations in 60 countries employing approximately 116,000 people worldwide. J&J implements a decentralized management approach as each of its operating companies functions as its own small business. Selling products in over 175 countries, J&J’s brands are recognized all over the world. J&J brands include numerous household names of medications and first aid supplies such as the Band-Aid brand line of bandages, Tylenol medications, Johnson’s baby products, Neutrogena skin and beauty products, Clean & Clear facial wash, and Acuvue contact lenses. J&J has had 27 consecutive years of adjusted earnings increases; and 49 consecutive years of dividend increases. Over the last 10 years, J&J stock generated a 4.0 percent total return for investors compared to a 1.4 percent total return for the S&P 500. J&J had sales of $16.6 billion for the second quarter of 2011, an increase of 8.3 percent as compared to the second quarter of 2010. Domestic sales increased only 0.1 percent, while international sales increased 15.9 percent. J&J’s Worldwide Pharmaceutical sales of $6.2 billion for the second quarter represented an increase of 12.2 percent versus the prior year. Domesticsales increased 4.1 percent but international sales increased 22.6 percent. J&J’s Worldwide Medical Devices and Diagnostics sles of $6.6 billion for the second quarter of 2011 represented increases of 7.2 and 13.4 percent, respectively, versus the prior year dometic and international sales.
การแปล กรุณารอสักครู่..